Award recordCONTRACT

SAGENT PHARMACEUTICALS, INC

PIID VA797P13C0024· VA Staff Offices· NAC PHARMACEUTICALS 36P797· 6505 · DRUGS AND BIOLOGICALS· FY2013· $0 net obligations· UEI PR1HCLM3FMW7· IL

Description

EXERCISING OPTION YEAR FOUR

Base award description: TOPOTECAN INJECTABLES

First action · last action
2013-02-07 · 2017-01-27
Transactions
9
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,784,300
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 9 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2013-02-07 · this action $0 · running total $0Modification P00002 · 2014-01-30 · this action $0 · running total $0Modification P00003 · 2015-01-23 · this action $0 · running total $0Modification P00004 · 2015-03-16 · this action $0 · running total $0Modification P00006 · 2016-01-07 · this action $0 · running total $0Modification P00007 · 2016-02-04 · this action $0 · running total $0Modification P00009 · 2016-02-29 · this action $0 · running total $0Modification P00010 · 2016-12-29 · this action $0 · running total $0Modification P00012 · 2017-01-27 · this action $0 · running total $0
  • Base2013-02-07+$0= $0
  • Mod P000022014-01-30+$0= $0
  • Mod P000032015-01-23+$0= $0
  • Mod P000042015-03-16+$0= $0
  • Mod P000062016-01-07+$0= $0
  • Mod P000072016-02-04+$0= $0
  • Mod P000092016-02-29+$0= $0
  • Mod P000102016-12-29+$0= $0
  • Mod P000122017-01-27+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-02-07+$0$0TOPOTECAN INJECTABLES
Mod P00002· EXERCISE AN OPTION2014-01-30+$0$0TOPOTECAN HCL 4MG/VIL INJ
Mod P00003· EXERCISE AN OPTION2015-01-23+$0$0EXERCISE OPTION YEAR 2 TOPOTECAN HCL 4MG/VIL INJ
Mod P00004· OTHER ADMINISTRATIVE ACTION2015-03-16+$0$0NDC CHANGE FOR TOPOTECAN HCL 4MG/VIL INJ
Mod P00006· OTHER ADMINISTRATIVE ACTION2016-01-07+$0$0NDC CHANGE FOR TOPOTECAN HCL 4MG/VIL INJ
Mod P00007· EXERCISE AN OPTION2016-02-04+$0$0EXERCISE 3RD OPTION YEAR FOR TOPOTECAN HCL 4MG/VIL INJ
Mod P00009· OTHER ADMINISTRATIVE ACTION2016-02-29+$0$0MOD TO DELETE OLD NDC 25021-0206-06 TOPOTECAN 4MG INJ
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-12-29+$0$02017 PL UPDATE
Mod P00012· EXERCISE AN OPTION2017-01-27+$0$0EXERCISING OPTION YEAR FOUR

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI PR1HCLM3FMW7)

AwardOffice · PSC / listingNet obligationsFY
36C77026P0086NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$275,580FY2026
36F79724D0107NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
V797D40094NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2014
VA69D12J198669D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS$181,705FY2012
VA69D12J155169D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS$3,846FY2012
VA69D12J148669D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS$110,561FY2012

Other recipients under 6505 from NAC PHARMACEUTICALS 36P797 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA797P17J0052MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$6,169FY2017
VA797P17J0051MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$17,881FY2017
VA797P17J0050MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$72,904FY2017
VA797P17J0048KREMERS URBAN PHARMACEUTICALS INC.NAC PHARMACEUTICALS 36P797$1,225,936FY2017
VA797P17J0053EXELAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$88,200FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P13C0024_3600 · retrieved 2026-09-26.